多药耐药临床分离株屎肠球菌和粪肠球菌通过噬菌体-抗生素协同作用的体外重敏。

IF 4.1 2区 医学 Q2 MICROBIOLOGY
Antimicrobial Agents and Chemotherapy Pub Date : 2025-02-13 Epub Date: 2024-12-19 DOI:10.1128/aac.00740-24
Pooja Ghatbale, Govind Prasad Sah, Sage Dunham, Ethan Khong, Alisha Blanc, Alisha Monsibais, Andrew Garcia, Robert T Schooley, Ana G Cobián Güemes, Katrine Whiteson, David T Pride
{"title":"多药耐药临床分离株屎肠球菌和粪肠球菌通过噬菌体-抗生素协同作用的体外重敏。","authors":"Pooja Ghatbale, Govind Prasad Sah, Sage Dunham, Ethan Khong, Alisha Blanc, Alisha Monsibais, Andrew Garcia, Robert T Schooley, Ana G Cobián Güemes, Katrine Whiteson, David T Pride","doi":"10.1128/aac.00740-24","DOIUrl":null,"url":null,"abstract":"<p><p>Bacteriophages are an increasingly attractive option for the treatment of antibiotic-resistant infections, but their efficacy is difficult to discern due to the confounding effects of antibiotics. Phages are generally delivered in conjunction with antibiotics, and thus, when patients improve, it is unclear whether the phages, antibiotics, or both are responsible. This question is particularly relevant for enterococcus infections, as limited data suggest phages might restore antibiotic efficacy against resistant strains. Enterococci can develop high-level resistance to vancomycin, a primary treatment. We assessed clinical and laboratory isolates of <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i> to determine whether we could observe synergistic interactions between phages and antibiotics. We identified synergy between multiple phages and antibiotics including linezolid, ampicillin, and vancomycin. Notably, antibiotic susceptibility did not predict synergistic interactions with phages. Vancomycin-resistant isolates (<i>n</i> = 6) were eradicated by the vancomycin-phage combination as effectively as vancomycin-susceptible isolates (<i>n</i> = 2). Transcriptome analysis revealed significant gene expression changes under antibiotic-phage conditions, especially for linezolid and vancomycin, with upregulated genes involved in nucleotide and protein biosynthesis and downregulated stress response and prophage-related genes. While our results do not conclusively determine the mechanism of the observed synergistic interactions between antibiotics and phages, they do confirm and build upon previous research that observed these synergistic interactions. Our work highlights how using phages can restore the effectiveness of vancomycin against resistant isolates. This finding provides a promising, although unexpected, strategy for moving forward with phage treatments for vancomycin-resistant <i>Enterococcus</i> infections.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":" ","pages":"e0074024"},"PeriodicalIF":4.1000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11823633/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>In vitro</i> resensitization of multidrug-resistant clinical isolates of <i>Enterococcus faecium</i> and <i>E. faecalis</i> through phage-antibiotic synergy.\",\"authors\":\"Pooja Ghatbale, Govind Prasad Sah, Sage Dunham, Ethan Khong, Alisha Blanc, Alisha Monsibais, Andrew Garcia, Robert T Schooley, Ana G Cobián Güemes, Katrine Whiteson, David T Pride\",\"doi\":\"10.1128/aac.00740-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bacteriophages are an increasingly attractive option for the treatment of antibiotic-resistant infections, but their efficacy is difficult to discern due to the confounding effects of antibiotics. Phages are generally delivered in conjunction with antibiotics, and thus, when patients improve, it is unclear whether the phages, antibiotics, or both are responsible. This question is particularly relevant for enterococcus infections, as limited data suggest phages might restore antibiotic efficacy against resistant strains. Enterococci can develop high-level resistance to vancomycin, a primary treatment. We assessed clinical and laboratory isolates of <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i> to determine whether we could observe synergistic interactions between phages and antibiotics. We identified synergy between multiple phages and antibiotics including linezolid, ampicillin, and vancomycin. Notably, antibiotic susceptibility did not predict synergistic interactions with phages. Vancomycin-resistant isolates (<i>n</i> = 6) were eradicated by the vancomycin-phage combination as effectively as vancomycin-susceptible isolates (<i>n</i> = 2). Transcriptome analysis revealed significant gene expression changes under antibiotic-phage conditions, especially for linezolid and vancomycin, with upregulated genes involved in nucleotide and protein biosynthesis and downregulated stress response and prophage-related genes. While our results do not conclusively determine the mechanism of the observed synergistic interactions between antibiotics and phages, they do confirm and build upon previous research that observed these synergistic interactions. Our work highlights how using phages can restore the effectiveness of vancomycin against resistant isolates. This finding provides a promising, although unexpected, strategy for moving forward with phage treatments for vancomycin-resistant <i>Enterococcus</i> infections.</p>\",\"PeriodicalId\":8152,\"journal\":{\"name\":\"Antimicrobial Agents and Chemotherapy\",\"volume\":\" \",\"pages\":\"e0074024\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11823633/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobial Agents and Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1128/aac.00740-24\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.00740-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

噬菌体是治疗抗生素耐药感染的一种越来越有吸引力的选择,但由于抗生素的混杂效应,它们的功效很难辨别。噬菌体通常与抗生素一起使用,因此,当患者病情好转时,尚不清楚是噬菌体、抗生素还是两者都起作用。这个问题与肠球菌感染特别相关,因为有限的数据表明噬菌体可能恢复抗生素对耐药菌株的疗效。肠球菌可以对万古霉素产生高度耐药性,万古霉素是一种主要的治疗方法。我们评估了临床和实验室分离的屎肠球菌和粪肠球菌,以确定我们是否可以观察到噬菌体和抗生素之间的协同相互作用。我们确定了多种噬菌体和抗生素之间的协同作用,包括利奈唑胺、氨苄西林和万古霉素。值得注意的是,抗生素敏感性不能预测与噬菌体的协同相互作用。万古霉素-噬菌体联合杀灭万古霉素耐药菌株(n = 6)与万古霉素敏感菌株(n = 2)同样有效。转录组分析显示,在抗生素-噬菌体条件下,基因表达发生了显著变化,尤其是利奈唑胺和万古霉素,参与核苷酸和蛋白质生物合成的基因表达上调,应激反应和前噬菌体相关基因表达下调。虽然我们的结果并不能最终确定抗生素和噬菌体之间观察到的协同相互作用的机制,但它们确实证实并建立在先前观察到这些协同相互作用的研究基础上。我们的工作强调了如何使用噬菌体可以恢复万古霉素对耐药分离株的有效性。这一发现提供了一个有希望的,虽然出乎意料的策略,推进噬菌体治疗万古霉素耐药肠球菌感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
In vitro resensitization of multidrug-resistant clinical isolates of Enterococcus faecium and E. faecalis through phage-antibiotic synergy.

Bacteriophages are an increasingly attractive option for the treatment of antibiotic-resistant infections, but their efficacy is difficult to discern due to the confounding effects of antibiotics. Phages are generally delivered in conjunction with antibiotics, and thus, when patients improve, it is unclear whether the phages, antibiotics, or both are responsible. This question is particularly relevant for enterococcus infections, as limited data suggest phages might restore antibiotic efficacy against resistant strains. Enterococci can develop high-level resistance to vancomycin, a primary treatment. We assessed clinical and laboratory isolates of Enterococcus faecium and Enterococcus faecalis to determine whether we could observe synergistic interactions between phages and antibiotics. We identified synergy between multiple phages and antibiotics including linezolid, ampicillin, and vancomycin. Notably, antibiotic susceptibility did not predict synergistic interactions with phages. Vancomycin-resistant isolates (n = 6) were eradicated by the vancomycin-phage combination as effectively as vancomycin-susceptible isolates (n = 2). Transcriptome analysis revealed significant gene expression changes under antibiotic-phage conditions, especially for linezolid and vancomycin, with upregulated genes involved in nucleotide and protein biosynthesis and downregulated stress response and prophage-related genes. While our results do not conclusively determine the mechanism of the observed synergistic interactions between antibiotics and phages, they do confirm and build upon previous research that observed these synergistic interactions. Our work highlights how using phages can restore the effectiveness of vancomycin against resistant isolates. This finding provides a promising, although unexpected, strategy for moving forward with phage treatments for vancomycin-resistant Enterococcus infections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信